Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Review fee comparisons across wide market index funds to find the lowest-cost option for retirement. Practical guidance to reduce recurring expenses.
28,610 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Ginnie Mae’s Joseph Gormley warns that risk-layered FHA portfolios pose new challenges for lenders and investors as l...
Magnite's 2025 earnings outlook centers on growing connected TV demand, platform efficiency, and navigating ad-tech p...
SpaceX going public soon would shake investor interest in the space economy. This guide shows how to position yoursel...
The U.S. Treasury must refinance about $8 trillion in debt over the next year, a record load that market watchers say...
Space investors are watching a highly anticipated IPO-style moment as SpaceX nears price levels. This guide breaks do...
AI data centers are pushing bandwidth limits, lifting demand for photonics. This report examines five notable players...
Oklo faces a pivotal Q1 2026 earnings night as it pivots from regulatory progress to early commercial milestones. Wat...
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
Two chipmakers lit up the market in the first half of 2026, but the big question remains: which is the smarter buy no...
When North West stepped onto the Paris stage with electric blue hair and punk flair, she sparked more than headlines—...
Tracking changes in your budget isn’t just about numbers. It’s a proactive habit that reveals spending patterns, aler...